Roquefort Therapeutics plc (LON:ROQ)

London · Delayed Price · Currency is GBP · Price in GBX

0.9500

-0.0500 (-5.00%)

Mar 26, 2026, 5:15 PM GMT

Roquefort Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.08	0.34	0.54	2.32	0.9
Cash & Short-Term Investments	0.08	0.34	0.54	2.32	0.9
Cash Growth	-76.85%	-37.26%	-76.87%	158.19%	-
Accounts Receivable	-	-	-	-	0.02
Other Receivables	0.03	0.01	0.11	0.05	2.14
Receivables	0.03	0.01	0.11	0.05	2.15
Prepaid Expenses	0.01	0.01	0.05	0.06	0.03
Total Current Assets	0.12	0.36	0.69	2.42	3.08
Property, Plant & Equipment	-	0.04	0.05	-	-
Goodwill	-	0.28	0.28	0.28	0.28
Other Intangible Assets	2.57	5.06	5.06	5.06	1.2
Total Assets	2.69	5.75	6.09	7.77	4.56

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.13	0.02	0.14	0.07	0.04
Accrued Expenses	0.14	0.16	0.16	0.21	0.15
Short-Term Debt	-	0.4	-	-	-
Total Current Liabilities	0.27	0.58	0.31	0.28	0.2
Long-Term Deferred Tax Liabilities	-	0.28	0.28	0.28	0.28
Total Liabilities	0.27	0.86	0.59	0.56	0.48

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1.64	1.36	1.29	1.29	0.72
Additional Paid-In Capital	4.76	4.62	4.4	4.4	3.46
Retained Earnings	-8.4	-5.27	-4.29	-2.55	-0.91
Comprehensive Income & Other	4.42	4.18	4.1	4.06	0.82
Shareholders' Equity	2.42	4.89	5.5	7.21	4.08
Total Liabilities & Equity	2.69	5.75	6.09	7.77	4.56

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	0.4	-	-	-
Net Cash (Debt)	0.08	-0.06	0.54	2.32	0.9
Net Cash Growth	-	-	-76.87%	158.19%	-
Net Cash Per Share	0.01	-0.00	0.04	0.22	0.36
Filing Date Shares Outstanding	16.37	13.57	12.92	12.92	7.19
Total Common Shares Outstanding	16.37	13.57	12.92	12.92	7.19
Working Capital	-0.16	-0.22	0.39	2.15	2.88
Book Value Per Share	0.15	0.36	0.43	0.56	0.57
Tangible Book Value	-0.16	-0.45	0.16	1.86	2.6
Tangible Book Value Per Share	-0.01	-0.03	0.01	0.14	0.36
Machinery	-	0.05	-	-	-